• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Cerus Corporation (CERS)

    -NasdaqGM
    4.21 Up 0.19(4.73%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.02
    Open:4.00
    Bid:4.10 x 1000
    Ask:4.40 x 100
    1y Target Est:8.25
    Beta:1.95
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:4.00 - 4.22
    52wk Range:3.48 - 7.03
    Volume:1,056,401
    Avg Vol (3m):1,452,790
    Market Cap:400.70M
    P/E (ttm):N/A
    EPS (ttm):-0.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CERS

    Comparison

    Symbol% ChgMkt Cap
    CERSUp 4.73%400.70M
    HAEDown 0.82%2.24B
    PLLUp 0.13%10.65B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.59
    Quarterly EPS Est (Mar-15) :-0.16
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback